|
|
| 5-Day | 11,922 |
| 10-Day | 43,624 |
| 30-Day | 31,168 |
| 5-Day | 11,922 |
| 10-Day | 43,624 |
| 30-Day | 31,168 |
| 5-Day | 332,962 |
| 10-Day | 368,669 |
| 30-Day | 352,468 |
| 5-Day | 332,962 |
| 10-Day | 368,669 |
| 30-Day | 352,468 |
Announcements
Dr Reddys Laboratories Q3 results on Jan 29, 2015
Top Trading Ideas
23 January 2015
buy AdaniPorts Jan Fut |
Entry Price (Rs) 343.00 |
Exit Price (Rs) 349.50 |
Gain (Rs) 7.00 |
buy DishTV Jan Fut |
Entry Price (Rs) 72.25 |
Exit Price (Rs) 75.00 |
Gain (Rs) 3.00 |
buy Siemens Jan Fut |
Entry Price (Rs) 1,025.00 |
Exit Price (Rs) 1,033.00 |
Gain (Rs) 8.00 |
buy ApolloHospital Jan Fut |
Entry Price (Rs) 1,235.00 |
Exit Price (Rs) 1,257.00 |
Gain (Rs) 22.00 |
| NSE SERIES | LAST PRICE | CHANGE(%) | OPEN | HIGH | LOW | FACE VALUE |
|---|---|---|---|---|---|---|
| N1 | 3,397.15 | 0.00% | 3,275.00 | 3,458.00 | 3,232.15 | 5 |
| Days | BSE | NSE |
| 30 | 3212.87 | 3214.21 |
| 50 | 3324.32 | 3325.97 |
| 150 | 3030.19 | 3030.98 |
| 200 | 2901.93 | 2902.83 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Dr Reddys Labs
| Consolidated | (Sep '14) | (Jun '14) |
| Net Sales | 3,587.81 | 3,517.54 |
| Other Income | 26.56 | 18.48 |
| PBDIT | 646.52 | 647.45 |
| Net Profit | 574.10 | 550.39 |
| Total Share Capital | 85.10 |
| Net Worth | 9329.00 |
| Total Debt | 2664.50 |
| Net Block | 2748.30 |
| Investments | 2806.50 |
| Net Current Assets | 5862.60 |
| Total Assets | 11993.50 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 923.75 | 0.59 | 938.90 | 552.50 | 191,323.77 |
| Lupin | 1489.35 | -0.93 | 1520.55 | 882.80 | 66,921.23 |
| Dr Reddys Labs | 3344.85 | -0.49 | 3662.00 | 2250.00 | 56,989.46 |
| Cipla | 674.75 | 3.15 | 684.45 | 366.70 | 54,177.12 |
| Aurobindo Pharm | 1177.50 | -0.24 | 1191.95 | 426.35 | 34,358.97 |
| More » | |||||
| Dec' 14 | Sep' 14 | Jun' 14 | Mar' 14 | |
| Promoter | 25.49 | 25.49 | 25.49 | 25.52 |
| FII | 38.53 | 38.41 | 35.29 | 34.30 |
| DII | 5.66 | 5.38 | 5.44 | 6.29 |
| Others | 30.32 | 30.72 | 33.78 | 33.89 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| Franklin India Bluechip Fund (G) | 552,335 |
| ICICI Prudential Focused Bluechip Equity Fund (G) | 335,927 |
| Birla Sun Life Frontline Equity Fund (G) | 335,367 |
| Franklin India Prima Plus Fund (G) | 255,942 |
Nile Recommended on Oct 23rd 2014
Recommended price 186.00 | Peak from reco 371.40 100.16%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Dr Reddys Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 56,989.46 crore.The company has reported a consolidated sales of Rs 3,587.81 crore and a Net Profit of Rs 574.10 crore for the quarter ended Sep 2014.
The company management includes Satish Reddy - Chairman, G V Prasad - Co-Chairman & Manag. Director, Anupam Puri - Independent Director, Ashok S Ganguly - Independent Director, Bruce L A Carter - Independent Director, J P Moreau - Independent Director, Sridar Iyengar - Independent Director, Kalpana Morparia - Independent Director, Ravi Bhoothalingam - Independent Director, Omkar Goswami - Independent Director.
It is listed on the BSE with a BSE Code of 500124 and the NSE with an NSE Code of DRREDDY.
Its Registered office is at 8-2-337, Road No. 3,,Banjara Hills Hyderabad,Telangana - 500034.
Their Registrars are Bigshare Services Pvt. Ltd.
SET SMS ALERT
